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Background: Second-hand smoke increases the risk of acute myocardial infarction. Canton Ticino (CT)
first introduced a smoking ban in public places in 2007. This offered the opportunity to assess the long-term
impact of a smoking ban on the incidence of ST-elevation myocardial infarctions (STEMI) compared
with a population where the law was not yet implemented. Methods: We assessed the incidence of STEMI
hospitalizations per 100 000 inhabitants both during 3 years before and after the ban application in CT
and in Canton Basel City (CBC), where this law was not yet applied. Data were obtained from the
codified hospital registry (ICD-10 codes). Results: In CT, the mean incidence of STEMI admissions during the 3
pre-ban years (123.7) was significantly higher than the incidence of admissions in each of the 3 post-ban years
(92.9, 101.6 and 89.6 respectively; P <.024). Analysing population subsets, a post-ban reduction was
observed among 65-year-old people of both sexes in each of the 3 post-ban years and in the <65-year age
group during the first post-ban year (P= 0.02). Conversely, the mean incidence of STEMI hospitalizations in
CBC (92.4) didn’t change significantly in each of the 3 post-ban years (83.9, 83.3 and 79.5, P=NS) during
the same period. However, a significant long-term reduction in STEMI admissions was observed in CBC
among the male group with 65 years (P< 0.01). Conclusion: Our work suggests a significant impact
of the smoke-free policy on the number of annual STEMI. Specific population subsets (i.e. 65-year-old
females) were particularly affected by the smoking ban, showing a significant reduction in STEMI
hospitalizations.
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Introduction
Second-hand smoke (SHS) increases the risk of coronaryartery disease (CAD) and acute myocardial infarction
(AMI).1–3 Both platelet activation and acute haemodynamic
response to smoke exposure may increase the risk of AMI
in relation to SHS. Such acute effects are probably transient
and disappear within a short time after cessation of exposure.4
Epidemiological studies suggest a decrease in the risk of
AMI within months after the cessation of exposure to active
and passive smoking.5,6 For these reasons, public health efforts
aimed at reducing tobacco consumption may have a significant
impact in the worldwide prevention of AMI.1 Canton Ticino
(CT) is one of the 26 Cantons of the Swiss Federation, representing
a well-defined political area with its own public health care
system. CT was the first Swiss canton to introduce a smoking
ban in April 2007, which prohibited tobacco consumption in
all public places, including public administrative buildings and
offices, cafe´s, bars, restaurants and discos. Because Switzerland
has a federal political system, smoking bans were enforced later
in other cantons, presenting a unique opportunity to compare
the epidemiology of AMI in two cantons with similar health
care systems but different legislation concerning the smoking
ban. Therefore, the aim of our study was twofold: (i) to
compare the incidence of hospitalization due to ST-elevation
myocardial infarction (STEMI) in CT before and after
the smoking ban enforcement and (ii) to compare the
contemporary incidence of STEMI in CT where the smoking
ban had not yet been implemented.
Methods
Location and demographic data
This retrospective observational study was conducted in two Swiss
Cantons, Ticino and Basel City. The Ethics Committee of both
Cantons approved the study protocol and the Swiss Federal
Statistical Office provided demographic data on the two
populations during the observational period (April 2004 to March
2010).
CT is located in southern Switzerland and represents a well-
defined geographical and political area with its own health
care system and with a population of 330 000 individuals,
during the observational period. In CT, there are four public
hospitals and one single institution (Cardiocentro Ticino, CCT)
that perform coronary interventions. CT was the first Swiss
Canton to enforce a smoking ban, on 12 April 2007, which
prohibited smoking in all public places. Since 1 May 2009, in CT
cigarette advertising too has been prohibited from all public
places (posters, public advertising). No public legislation has been
approved in order to prevent cigarette selling to young people.
Such policy will probably be implemented on 1 June 2013.
Canton Basel City (CBC) is located in northern Switzerland and
had a population of 192 000 individuals during the observational
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period. CBC has only one public hospital that performs coronary
interventions and cares for patients with AMI. Similar to CT, the
national border delimited CBC but in contrast to CT, there is no
major geographical barrier towards the nearby Cantons. In CBC, the
smoking ban law was not enforced until April 2010. However, since
1 January 2005, cigarette advertising has been prohibited in CBC
from all public places (posters, public advertising). Moreover,
cigarette selling to young people (<16 years) has been prohibited
since 1 August 2007 and forbidden for minors (<18 years) since 1
January 2009, as well as cigarette distribution from vending
machines.
Study population
In CT, the period of interest included the 3 years before (from April
2004 to March 2007) and the 3 years after the smoking ban (from
April 2007 to March 2010). Each year was computed from the 12th
of April to the 11th of the following April and did not correspond to
the calendar year. In CBC, data were available only for 2 years before
the smoking ban in CT (from April 2005 to March 2007) and for the
3 years after the smoking ban (from April 2007 to March 2010). We
retrospectively collected data of all patients discharged for STEMI
(survivors and non-survivors) in CT and CBC during the observed
period. Records were acquired from the codified hospital discharge
registry (ICD-10 codes: I21.0, I21.1, I21.2 and I21.3) in the form of
anonymized data concerning date of hospitalization, age and sex.
For our analysis, we considered only the resident patients of CT and
CBC.
Statistical methods
We tested the hypothesis that the enforcement of the smoking ban in
CT was associated with changes in the annual number of admissions
for STEMI during a 3-year period when the law was in effect. We
compared the number of admissions during the 3 years when the law
was in effect (2007–08, 2008–09 and 2009–10) with the average
number of admissions during the same period in the years before
(2004–05, 2005–06 and 2006–07). Incidence of admissions due to
STEMI was calculated both in absolute numbers and per 100 000
inhabitants. Subgroups by age (<65 and 65 years) and gender were
also considered. All calculations were performed on incidence of
STEMI per 100 000 inhabitants for both CT and CBC, to correct
the potential migrant effect played by the varying population over
time. All comparisons were conducted on the assumption of a
Poisson distribution of the number of admissions. Incidence per
100 000 inhabitants during the 3 years before and after the ban in
CT was compared between the two Cantons. Comparability of
patients hospitalized for STEMI in the two Cantons according to
sex and age was verified using 2 and Student’s t-tests for independ-
ent samples. The significance level was set to = 0.05, two-sided.
Descriptive statistics of continuous variables are shown as
mean standard deviation. Statistical analysis was performed with
SPSS version 19 and SAS version 8.
Results
Canton Ticino
We identified a total of 1733 residents (70% men, mean age
67.4 14 years) in CT discharged with the ICD-10 diagnosis of
STEMI during the entire observational period (April 2004–March
2010). Absolute number of STEMI hospitalizations and patients’
characteristics are outlined in table 1. The mean number of annual
STEMI admissions during the 3 years before the smoking ban (323)
was significantly higher than the number of admissions in each of
the 3 years after the smoking ban (247, 274 and 244 respectively;
P= 0.002, P= 0.024 and P= 0.001). The overall annual incidence of
hospitalizations because of STEMI was 122.8, 134.9 and 114.2 per
100 000 inhabitants during the 3 years before the implementation of
the smoking ban in public places. During the 3 years following the
enforcement of the new legislation, the incidence of hospitalization
due to STEMI significantly decreased to 92.9, 101.6 and 89.6
(P= 0.02, P= 0.024 and P= 0.001) respectively. This corresponds
to an estimated STEMI reduction of 23.5% (95% CI: 6.5% to
37.4%), 15.1% (95% CI: 2.4% to 26.10%) and 24.1%
(95%CI: 7.5% to 38.2%) during the first, second and third
year after the introduction of the ban, respectively, compared with
the mean pre-ban 3-year period (Supplement figure 1).
Moreover, analysing population subsets, a significant reduction of
annual STEMI incidence was observed after the enforcement of the
smoking ban among 65-year-old people of both sexes within each
year after the ban. In particular, among 65-year-old women, the
number of STEMI decreased by 26.6, 22.8 and 32.9% during the
first, second and third year after the introduction of the ban.
Similarly, 65-year-old men showed 21.4, 23.9 and 36.8%
reduction during the same years.
Considering <65-year-old people, the mean incidence of annual
STEMI admissions during the 3 pre-ban years significantly decreased
among men in the first year after the ban enforcement (109.0 vs.
85.3, P= 0.01). Also among <65-year-old female patients, a decrease
close to significance was observed in the first year after the ban
enforcement (19.5 vs. 12.8, P= 0.066 NS). No significant decrease
was observed in the second and third year among men or women.
figure 1.
Table 1 Canton Ticino: admissions for STEMI during the 3 years period before and the 3 years period after the ban
All
population
Before the official ban After the official ban P-valuea vs. mean before ban
2004–05 2005–06 2006–07 Mean before
Ban
2007–08 2008–09 2009–10 2007–08 2008–09 2009–10
N 316 352 300 323 247 274 244
Incidence 100 000
inhabitants
122.8 134.9 114.2 123.7 92.9 101.6 89.6 P=0.002 P=0.024 P=0.001
Age Sex Incidence per 100 000 inhabitantsb
<65
years
Male 106.1 122.1 102.2 109.0 85.3 102.5 101.6 P=0.010 P=0.270 P=0.270
Female 22.8 15.8 19.7 19.5 12.8 21.5 14.6 P=0.066 P=0.072 P=0.105
Both sexes 63.7 68.0 60.2 63.9 48.4 61.4 57.5 P=0.023 P=0.389 P=0.214
65
years
Male 418.2 555.9 418.3 464.1 340.3 318.4 256.4 P=0.000 P=0.000 P=0.000
Female 242.0 207.7 187.3 212.3 149.9 154.3 131.4 P=0.000 P=0.000 P=0.000
Both sexes 322.6 358.1 287.7 322.8 225.2 218.2 179.2 P=0.000 P=0.000 P=0.000
a: Assuming Poisson distribution of data.
b: Incidence per 100 000 inhabitants for the total admissions and per 100 000 inhabitants by age class and sex for the subgroups.
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Demographic data concerning the population of CT during the
observation period are outlined in Supplementary table S1. The
population slightly increased (from 319 931 to 335 720 inhabitants)
during the period of interest as well as the proportion of people aged
65 years (from 18.6 to 20.2%). Such population aging over time
potentially accounted for a slight increase in the ‘expected’ incidence
of STEMI over time in CT. However, because the ‘observed’
incidence of STEMI decreased, we could indirectly exclude a signifi-
cant effect of population aging over time.
Canton Basel City
A total of 672 residents discharged with a diagnosis of STEMI from
the University Hospital in CBC (mean age 68.4 14.4 years, 64.7%
men) were included in the present study. Absolute number of
STEMI hospitalizations and patient’s characteristics are outlined in
table 2. In this Canton, where the smoking ban had not yet been
implemented, no significant change was observed in the number of
annual STEMI, comparing the years before and after the implemen-
tation of the smoking ban in CT. In particular, from April 2007,
when the smoking ban was enforced in CT, the annual incidence of
STEMI per 100 000 inhabitants for the 3-year period was 83.9, 83.3
and 79.5, reflecting a non-significant reduction compared to the
mean value of the pre-ban years (92.4) (P= 0.219, P= 0.189,
P= 0.114 NS) (Supplementary figure S2). However, when
analysing subgroups by gender and age, 65-year-old males
showed a significant decrease in the incidence of STEMI
admissions in each of the 3 years after the smoking ban (223.6,
234.4 and 199.8; P< 0.01, P< 0.01 and P< 0.01) compared with
the mean value of the pre-ban years (362.4) (figure 2).
Demographic data concerning the population of CBC during the
observation period are outlined in Supplementary table S1. The
population slightly increased (from 186 753 to 187 898 inhabitants)
during the period of interest, while the proportion of people aged
65 years remained unchanged (from 20.7 to 20.2%).
Using a Poisson regression model, we also compared the
incidence of STEMI in CT and CBC, before the introduction of
the smoking ban in CT and afterwards. The STEMI incidence was
significantly lower in CBC both before (23.6%, P= 0.009, 95% CI:
37.6 to 6.4%), and after (23.0%, P= 0.041, 95% CI: 40.0 to
1.0%).
Discussion
The present study provides demonstration for a significant and long-
lasting reduction in the incidence of STEMI admissions among the
overall population of CT after the enforcement of a smoking ban in
public places. We observed a 21.1% mean reduction in the incidence
of STEMI hospitalizations, which is in line with the results of prior
reports showing a comparable reduction of acute coronary events
after the introduction of similar smoke-free legislations.7–13 In
particular, as we can appreciate from the longer observation
period of our study, the decrease in acute coronary events seems
not to be a merely transient phenomenon. Benefits were present on
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Figure 1 Incidence of STEMI hospitalization per 100 000 inhabitants
in Canton Ticino, by age class and sex
*Significant changes comparing mean incidence before ban with
each subsequent year, assuming Poisson distribution
Table 2 Canton Basel City. Admissions for STEMI during the 2 years period before and the 3 years period after the ban in CT
All
population
Before the official ban in Ticino After the official ban in Ticino P-valuea vs. mean before ban
2004–05 2005–06 2006–07 Mean before
Ban
2007–08 2008–09 2009–10 2007–08 2008–09 2009–10
N 163 124 144 130 130 125
Incidence 100000 inhabitants 104.8 80.0 92.4 83.9 83.3 79.5 P=0.219 P=0.189 P=0.114
Age Sex Incidence per 100 000 inhabitantsb
<65 years Male 97.4 66.6 82.0 91.1 64.3 79.1 P=0.853 p=0.023 P=0.398
Female 18.8 13.7 16.2 12.0 22.1 21.9 P=0.193 P=0.942 P=0.942
Both sexes 57.7 39.8 48.7 51.1 43.0 48.5 P=0.663 P=0.231 P=0.498
65 years Male 386.7 338.1 362.4 223.6 234.4 199.8 P=0.000 P=0.000 P=0.000
Female 155.2 110.9 133.1 152.3 181.0 144.7 P=0.952 P=0.999 P=0.894
Both sexes 243.2 197.8 220.5 179.8 201.7 156.1 P=0.003 P=0.10 P=0.000
a: Assuming Poisson distribution of data.
b: Incidence per 100 000 inhabitants for the total admissions and per 100 000 inhabitants by age class and sex for the subgroups.
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Figure 2 Incidence of STEMI hospitalization per 100 000 inhabitants
in Canton Basel City, by age class and sex
*Significant changes comparing mean incidence before ban in CT
with each subsequent year, assuming Poisson distribution
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the whole population even 3 years after the introduction of the
smoking ban. Multiple mechanisms related to nicotine consump-
tion—such as platelet activation, endothelial dysfunction, arterial
stiffness, oxidative stress, decreased antioxidant defence, vascular
inflammation and reduction of the parasympathetic tone—provide
biological plausibility for the observed reduction of STEMI after the
enforcement of the smoke-free legislation.4
However, the analysis of age- and sex-standardized data allowed
us to better understand the internal dynamics of such change in
STEMI hospitalizations, keeping in mind the intrinsic limitations
of sub-analysis associated with relatively small sample size. During
the post-ban period, a significant and long-lasting reduction of
STEMI admissions was observed only among 65-year-old people
of both sexes. On the other hand, younger people (i.e. <65 years)
showed a reduction (statistically significant in men, with a trend
toward significance in women) in STEMI admissions only in the
first year, with no significant decrease in the second and third year
after the ban enforcement. According to the recent work of Giovino
et al.,14 the mean current smoking prevalence in 65-year-old
people calculated over 16 different countries of the world is about
16.8%, much lower than in younger people. Data from the
University of Zurich15 concerning the smoking habit of the Swiss
population from 2001 till 2010 suggest a decreasing prevalence of
active smokers with increasing age. Therefore, passive smoking plays
the most important role in such class of age, characterized by a
greater time of exposure to free-smoking attempts too. Thus, it is
not surprising that the persisting decrease of passive smoking caused
by the free-smoke legislation is associated with a long-term
reduction in the number of STEMI admissions among people aged
65 years of age.
Another point is represented by the comparison of data between
CT and CBC where the smoking ban had not yet been introduced.
CT was the first Canton of Switzerland to introduce the smoking ban
in public places, followed by Canton Graubu¨nden, where an overall
22% reduction in the rate of acute myocardial infarction was
observed within the first and second years after enactment of the
public smoking ban.16,17 Bonetti et al16 observed a reduction of
STEMI (17%) similar to our results one year after the introduction
of a smoking ban in Canton Graubu¨nden.16 In CBC, no significant
change was appreciated among the whole population in the number
of annual STEMI, comparing the years before and after the imple-
mentation of the smoking ban in CT. However, analysing age- and
sex-standardized values, 65-year-old male patients showed a sig-
nificant long-term decrease in the number of STEMI admissions in
each of the 3 years after the smoking ban. This result seems to
suggest that the significant STEMI reduction among 65-year-old
males (appreciated in CT as well as in CBC where the ban was not
yet implemented) may be mostly explained by ban-independent
reasons such as smoking habit changes of male smokers. Several
studies performed in different countries18–20 demonstrated a
higher proportion of former smokers among males aged 65 years
probably due to a higher health awareness and to a greater
perception of vulnerability, especially after having been attempted
by smoking-related health problems. The improvement of primary
and secondary cardiovascular prevention during the observational
period and a more aggressive attitude towards both prevention and
treatment of the greatest subset (65-year-old males) of STEMI
population21–23 may represent further explanations.
Conversely, STEMI reduction among 65-year-old females seems
to represent a direct result of the smoking ban enforcement, as
demonstrated by the absence of effect in CBC. In other
words, although a similar post-ban mean STEMI reduction (25.6%
among women and 22.3% among men, in CT), only among
65-year-old females, STEMI decrease seems to reflect a ban intro-
duction-related effect. Our result totally agrees with several
studies24,25 demonstrating a greater impact of second-hand smoke
and consequently of smoke-free policies among women. Such result
may be probably explained by several reasons. As suggested by
Oeberg et al.,25,26 the number of non-smoker women exceeds by
the 60% that of non-smoker males, identifying a greater
population susceptible, by definition, to second-hand smoke
exposure and smoke-free interventions as well. Pell et al.24 also
demonstrated a lower post-ban exposure to second-hand smoke
among non-smoker women, showing lower cotinine concentrations
after smoking ban enforcement. Moreover women, who probably
share a greater relative risk associated with smoking, show a
sharper dose-response as well.24,27 Through its pro-thrombotic
effects, smoking may contribute to thrombus formation on eroded
plaques and such event has been demonstrated to be particularly
common in women’s acute coronary syndromes.24,28
Finally, comparing the annual STEMI incidences between CT and
CBC, the latter showed significantly lower values both before and
after the ban enforcement. This finding remains unexplained. It
seems very unlikely that relevant differences in primary and
secondary prevention or in acute treatment of STEMI may be
responsible for such differences.
A particular clarification should be mentioned for patient
selection. In contrast to previous studies reporting the incidence
of acute coronary syndrome or non-specified myocardial
infarction,7–13,17–18 we specifically considered only the diagnosis of
STEMI whose identification is based on an indisputable persistent
ST-segment elevation at the ECG. Conversely, the diagnosis of
NSTEMI is based on ECG changes and cardiac biomarker
elevations (i.e., the serum troponin level above a normal
threshold). This makes uncertain the reported ICD-10 code
diagnosis of NSTEMI during observational studies, especially when
this diagnosis is based on different thresholds of cardiac biomarkers,
as occurred during the observational period in our study. In fact, in
the 3 years after the introduction of the smoking ban, we observed a
notable increase in NSTEMI hospitalizations (mean +110%).
However, during the observational period, the troponin T
threshold was reduced on two occasions and, in 2007, troponin
T was replaced by troponin I. This course of non-ST-elevation
myocardial infarction mirrors the data published by Yeh et al.29 In
particular, the increased incidence of NSTEMI closely reflects the
increase in troponin testing and demonstrates how changing a
biomarker or its threshold affects the rate of NSTEMI diagnosis.29
Study limitations
Our study presented several limitations. First, the current study was
conceived on an ICD code-based design that did not allow the
assessment for further patient information (besides age, sex and
date of admission) such as smoking habits, cardiovascular risk
factors, socio-economic status and other prevention and treatment
strategies. Moreover, the limited sample size prevented a multivariate
analysis taking into account other potential confounders or causes of
the observed decline in STEMI events. For this reason, we could not
control data for air pollution, infection disease epidemics or holidays,
which are well-known factors associated with the development of
acute cardiovascular events. Furthermore, the statistical approach
(based on the assumption of a Poisson distribution of the number
of admissions) does not consider the secular trend of decreasing hos-
pitalizations over time. However, the limited number of STEMI ob-
servations and the short span of time preceding and following the
smoking ban prevented a more complex statistical approach to
account for the analysis of secular trend. Finally, out-of-hospital
deaths due to presumptive STEMI were not considered in this study.
Conclusions
Our work represents one of the few studies that investigate the long-
term change in the annual number of STEMI admissions after the
enforcement of a smoking ban in public places. We demonstrated a
long-term post-ban reduction in the incidence of STEMI admissions
among the overall population of CT.
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Supplementary data
Supplementary data are available at EURPUB online.
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Key points
 Our work represents one of the few studies that investigate
the long-term change in the annual number of admissions
due to ST-segment elevation myocardial infarction after the
enforcement of a smoking ban in public places.
 A major point of the study is represented by the comparison
of data between two cantons of Switzerland, Canton Ticino
and Canton Basel City where the smoking ban had not yet
been introduced.
 Our study corroborates the results of previous studies
showing a reduction of acute coronary syndromes after the
introduction of smoking ban in public places and underlines
the public health implications of smoking bans.
 The results of the current study seem to confirm that
smoke-free policies may offer a simple and inexpensive
intervention for the prevention of cardiovascular diseases
and should be included in prevention programs worldwide.
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